EW

SELL

Edwards Lifesciences Corporatio

Healthcare · Rank #119 · Analyzed Jul 13, 2026

$92.21

Current Price

$30.41

Intrinsic Value

-67.0%

Upside/Downside

4/10

Score

4/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score4/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 67.0%

Fair Value Range

Low$10.34

Base (IV)$30.41

High$37.83

Entry Points

Conservative$7.24

Moderate$10.34

Aggressive$21.29

Quality & Moat Breakdown

Return on Equity10.5% → 0.5/1.0

Debt LevelD/E 7 → 1.0/1.0

Revenue QualityGrowth 19.4%, margin Δ-32.0% +recovery → 1.0/1.0

Moat Strength3.0/5 → 0.5/1.0

Profit Margins17.4% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.